HEDY MIGDEN: Open Payments
NPI 1568422483 · LOUDONVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$764 in 38 payments from 19 companies in 2025. Trend: 2023 $1,067 · 2024 $1,154 · 2025 $764
Food & beverage: $764
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $111 |
| Otsuka America Pharmaceutical, Inc. | 4 | $92 |
| Lilly USA, LLC | 4 | $73 |
| Exact Sciences Corporation | 3 | $70 |
| Novo Nordisk Inc | 3 | $55 |
| Indivior Inc. | 2 | $41 |
| Lundbeck LLC | 2 | $39 |
| Merck Sharp & Dohme LLC | 2 | $34 |
| Axsome Therapeutics, Inc. | 2 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $30 |
Products named: REXULTI, ZEPBOUND, VRAYLAR, Wegovy, The Cologuard Plus Collection Kit, SUBLOCADE, GARDASIL 9, QULIPTA.
Industry payments across NY — which companies pay providers there.
